In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1569-16-0, name is 2-Methyl[1,8]-Naphthyridine, introducing its new discovery. Recommanded Product: 2-Methyl[1,8]-Naphthyridine
In our continuing efforts to identify small molecule vitronectin receptor antagonists, we have discovered a series of phenylbutyrate derivatives, exemplified by 16, which have good potency and excellent oral bioavailability (approximately 100% in rats). This new series is derived conceptually from opening of the seven-membered ring of SB-265123.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1569-16-0, and how the biochemistry of the body works.Recommanded Product: 2-Methyl[1,8]-Naphthyridine
Reference£º
1,359-Naphthyridine – Wikipedia,
1,8-Naphthyridine | C8H6N353 – PubChem